Jeremy Lieb, MD, discusses a test that enables physicians to actively monitor a patient’s prostate cancer and choose less aggressive forms of treatment for less advanced cases, ultimately helping some...
Tim Turnham, PhD, Executive Director of the Melanoma Research Foundation, discusses the USPSTF's recent decision to reverse its position that annual skin screenings are recommended for all adults.
Craig A. Dionne, PhD, CEO of GenSpera, describes some of the drawbacks associated with common cancer treatments. Many types of drug therapies, like antiangiogenics and immunotherapies, may only be effective...
Susan Prockop, MD, discusses the risk of developing a tumor or lymphoma following a stem cell or organ transplant in patients with Epstein-Barr virus who have had a bone marrow transplant.
Hayley Adams, DVM, PhD, DACVPM, DACVM, discusses the available information on Zika virus, including potential vaccines, preventive measures, and the focus on treating symptoms.
Stevin Zorn, PhD, discusses research into exploitation of a single mechanism of action for possible treatment and prevention of Alzheimer disease, and a possible shift of focus towards experimenting with...
Santosh Kesari, MD, PhD, discusses a new prodrug that targets cells with a high level of PSMA expression, a protein that is present in many cancerous tumors.
Rashmi Roy, MD, FACS, endocrine surgeon for the University Medical Center of Princeton at Plainsboro, outlines how adrenal tumors can cause patients to display symptoms of hypertension and diabetes.
